Comparison of in vitro antibacterial activities for different ratio of amoxicillin/sulbactam
Xiuzhen Zhang
Abstract
Xiuzhen Zhang
Abstract
Objective:To evaluate the antibacterial activities in vitro of amoxicillin/sulbactam (2:1 and 4:1). Methods:Minimal inhibitory concentrations (MIC) were determined by agar double dilution. Of 620 strains of clinical organisms, 502 cultures of organisms were found to be able to produce β-lactamases (80.97%). Results:Two combinations of amoxicillin/sulbactam (2:1 and 4:1) all showed resistant antibacterial activities with fluctuated MIC range,MIC50 and MIC90 in 1-2 times on the following organisms: Escherichia coli of ESBL, Klebsiella pneumoniae of ESBL, Enterobacter spp producing AmpC enzyme and non-fermentation gram negative rod ( Pseudomonas aeruginosa , Acineto-bacter spp, Stenophotomonas maltophilus). Two combinations of amoxicillin/sulbactam (2:1 and 4:1) also gave an equivalent titer in the MIC range,MIC50 and MIC90 on common pathogenic bacteria that cause community infection,i.e. ,Haemophilus Influenza producing β-lactamases,Moraxella catarrh , MSSA and MSSCoN, Streptococcus pneumoniae, β-haemolysis Streptococcus and Enterococcus fae-calis. Conclusion: Amoxicillin/sulbactam (4:1) was found to have the same antibacterial activity as amoxicillin/sulbactam (2:1).
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate the antibacterial activities in vitro of amoxicillin/sulbactam (2:1 and 4:1). Methods:Minimal inhibitory concentrations (MIC) were determined by agar double dilution. Of 620 strains of clinical organisms, 502 cultures of organisms were found to be able to produce β-lactamases (80.97%). Results:Two combinations of amoxicillin/sulbactam (2:1 and 4:1) all showed resistant antibacterial activities with fluctuated MIC range,MIC50 and MIC90 in 1-2 times on the following organisms: Escherichia coli of ESBL, Klebsiella pneumoniae of ESBL, Enterobacter spp producing AmpC enzyme and non-fermentation gram negative rod ( Pseudomonas aeruginosa , Acineto-bacter spp, Stenophotomonas maltophilus). Two combinations of amoxicillin/sulbactam (2:1 and 4:1) also gave an equivalent titer in the MIC range,MIC50 and MIC90 on common pathogenic bacteria that cause community infection,i.e. ,Haemophilus Influenza producing β-lactamases,Moraxella catarrh , MSSA and MSSCoN, Streptococcus pneumoniae, β-haemolysis Streptococcus and Enterococcus fae-calis. Conclusion: Amoxicillin/sulbactam (4:1) was found to have the same antibacterial activity as amoxicillin/sulbactam (2:1).
Key concepts: Microbiology, Amoxicillin, Sulbactam, Streptococcus pneumoniae, Haemophilus, Agar dilution, Klebsiella pneumoniae, Biology